How Much Did PEAK BioSource Raise?
Funding & Key Investors

PEAK BioSource has successfully secured a major strategic investment, bringing its total capital accumulation to $136K. This latest infusion of $136K underscores the firm's robust trajectory within the specialized human capital sector. By leveraging this financial backing, the organization is positioned to solidify its influence in the high-stakes recruitment landscape for life sciences, ensuring that critical talent acquisition needs are met with precision and scale.

What is PEAK BioSource?

PEAK BioSource
Business ServicesHuman Resources Management Systems (HRMS)

PEAK BioSource operates as a specialized executive search and recruitment consultancy, focusing exclusively on the pharmaceutical, biotechnology, and medical device industries. The firm distinguishes itself through a high-touch, network-driven approach that addresses the acute talent shortages prevalent in R&D and clinical development sectors. By providing customized and flexible recruitment solutions, PEAK BioSource acts as a vital intermediary, bridging the gap between top-tier scientific talent and organizations tasked with bringing life-saving innovations to market. Their market position is defined by deep domain expertise and a commitment to long-term partnership, which is essential for navigating the complex regulatory and technical requirements of the life sciences ecosystem.

How much funding has PEAK BioSource raised?

PEAK BioSource has raised a total of $136K across 1 funding round:

2021

Debt

$136K

Debt (2021): $136K with participation from PPP

Key Investors in PEAK BioSource

PPP

Public-Private Partnership

What's next for PEAK BioSource?

With the recent influx of capital, PEAK BioSource is expected to accelerate its operational expansion and enhance its proprietary recruitment technology stack. The firm will likely focus on scaling its internal team of specialized recruiters to meet the growing demand for executive-level talent in the biotech sector. Furthermore, the strategic nature of this funding suggests a move toward broader market penetration, potentially exploring new geographic hubs or diversifying its service offerings to include interim leadership and consulting services. As the life sciences industry continues to face intense competition for specialized human capital, PEAK BioSource is well-positioned to leverage its financial resources to become the primary talent partner for emerging and established pharmaceutical entities alike.

See full PEAK BioSource company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)Project Management
Business ServicesProject Management
Business ServicesDocument ManagementAccounting for Legal Practices

Frequently Asked Questions Regarding PEAK BioSource Financial Insights

What are the most recent funding rounds that PEAK BioSource has completed, and what were the funding rounds?
PEAK BioSource has recently completed 1 funding rounds: Debt on Jan 26, 2021.
What is the total amount of funding PEAK BioSource has raised to date?
PEAK BioSource has raised a total of $136K in funding to date.
How many funding rounds has PEAK BioSource completed?
PEAK BioSource has completed 1 funding rounds.
How much funding did PEAK BioSource raise in its most recent funding round?
PEAK BioSource raised $136K in its most recent funding round.
Who are the lead investors in PEAK BioSource's latest funding round?
The lead investor in PEAK BioSource's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PEAK BioSource's history?
The largest funding round in PEAK BioSource's history was $136K.
See more information about PEAK BioSource